Evaluation of Relaxin's Antifibrotic Action by SELDI‐TOF Mass Spectrometry‐Based Profiling of Relaxin Knockout Mice, a Model of Progressive Fibrosis

Surface-enhanced laser desorption ionization–time-of-flight mass spectrometry was employed to identify potential biomarkers for early-onset fibrosis. These biomarkers were then used to evaluate the efficacy of relaxin to reverse or ameliorate the development of the condition.